Your browser doesn't support javascript.
loading
JAK2 V617F polycythemia vera and essential thrombocythemia: dynamic clinical features associated with long-term outcomes.
Sureau, Léa; Buors, Caroline; Ianotto, Jean-Christophe; Boyer, Françoise; Tanguy-Schmidt, Aline; Roy, Lydia; Cayssials, Emilie; Cailly, Laura; Chomel, Jean-Claude; Chauveau, Aurélie; Orvain, Corentin; Mansier, Olivier; Ranta, Dana; Robles, Margot; Gyan, Emmanuel; Hérault, Olivier; Nimubona, Stanislas; Marchand, Tony; Lippert, Eric; Riou, Jérémie; Ugo, Valérie; Luque Paz, Damien.
Afiliação
  • Sureau L; CHU Angers, Laboratoire d'Hématologie, Angers, France.
  • Buors C; Univ Angers, Nantes Université, CHU Angers, Inserm, CNRS, CRCI2NA, F-49000, Angers, France.
  • Ianotto JC; Fédération Hospitalo-Universitaire "Grand Ouest Against Leukemia" (FHU GOAL), Angers, France.
  • Boyer F; Fédération Hospitalo-Universitaire "Grand Ouest Against Leukemia" (FHU GOAL), Angers, France.
  • Tanguy-Schmidt A; CHU Brest, Laboratoire d'Hématologie, Brest, France.
  • Roy L; Fédération Hospitalo-Universitaire "Grand Ouest Against Leukemia" (FHU GOAL), Angers, France.
  • Cayssials E; CHU Brest, Service d'Hématologie Clinique, Brest, France.
  • Cailly L; Fédération Hospitalo-Universitaire "Grand Ouest Against Leukemia" (FHU GOAL), Angers, France.
  • Chomel JC; CHU Angers, Service des Maladies du Sang, Angers, France.
  • Chauveau A; Univ Angers, Nantes Université, CHU Angers, Inserm, CNRS, CRCI2NA, F-49000, Angers, France.
  • Orvain C; Fédération Hospitalo-Universitaire "Grand Ouest Against Leukemia" (FHU GOAL), Angers, France.
  • Mansier O; CHU Angers, Service des Maladies du Sang, Angers, France.
  • Ranta D; Hôpital Universitaire Henri Mondor, Service Hématologie Clinique, APHP & UPEC, UFR de Santé, Créteil, France.
  • Robles M; Fédération Hospitalo-Universitaire "Grand Ouest Against Leukemia" (FHU GOAL), Angers, France.
  • Gyan E; CHU Poitiers, Service d'Oncologie Hématologique et Thérapie Cellulaire, Poitiers, France.
  • Hérault O; CHU Poitiers, Service d'Oncologie Hématologique et Thérapie Cellulaire, Poitiers, France.
  • Nimubona S; Fédération Hospitalo-Universitaire "Grand Ouest Against Leukemia" (FHU GOAL), Angers, France.
  • Marchand T; CHU Poitiers, Service de Cancérologie Biologique, Poitiers, France.
  • Lippert E; CH de Cornouaille, Laboratoire d'Hématologie, Quimper, France.
  • Riou J; Univ Angers, Nantes Université, CHU Angers, Inserm, CNRS, CRCI2NA, F-49000, Angers, France.
  • Ugo V; Fédération Hospitalo-Universitaire "Grand Ouest Against Leukemia" (FHU GOAL), Angers, France.
  • Luque Paz D; CHU Angers, Service des Maladies du Sang, Angers, France.
Blood Cancer J ; 12(4): 56, 2022 04 08.
Article em En | MEDLINE | ID: mdl-35395836
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Policitemia Vera / Janus Quinase 2 / Mielofibrose Primária / Trombocitemia Essencial Tipo de estudo: Diagnostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Blood Cancer J Ano de publicação: 2022 Tipo de documento: Article País de afiliação: França
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Policitemia Vera / Janus Quinase 2 / Mielofibrose Primária / Trombocitemia Essencial Tipo de estudo: Diagnostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Blood Cancer J Ano de publicação: 2022 Tipo de documento: Article País de afiliação: França